On behalf of the Board of Directors of the Company, it gives us immense pleasure in presenting the Ninth Board's Report, along with the Audited Financial Statements (Standalone and Consolidated) for the financial year ending March 31, 2026.
1. FINANCIAL PERFORMANCE
The Company has prepared the Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, in accordance with the Indian Accounting Standards (Ind AS) as prescribed under the Companies Act, 2013.
Key highlights of financial performance of the Company for the financial year ending March 31, 2026, as compared to previous year are provided below:
| |
Standalone
|
Consolidated
|
| |
2025-26
|
2024-25
|
2025-26
|
2024-25
|
|
Financial Results
|
|
Gross Revenue
|
1,374.87
|
1292.90
|
1,375.14
|
1292.08
|
|
Profit before Interest, Depreciation, Tax and Amortization
|
192.57
|
212.98
|
192.91
|
214.6
|
|
Profit before tax
|
(7.24)
|
(1.08)
|
(7.41)
|
0.54
|
|
Profit after tax
|
(7.24)
|
(1.08)
|
(7.41)
|
0.54
|
|
EPS (basic & diluted) on the basis of ' 10/- per share
|
(1.64)
|
(0.27)
|
(1.68)
|
0.14
|
2. BUSINESS OVERVIEW
We are a global pure-play Active Pharmaceutical Ingredients (API) company engaged in the development and manufacture of APIs, alongside providing CDMO services to pharmaceutical companies worldwide. Our operations are anchored by six world-class, multi-product manufacturing facilities and supported by a talented workforce of nearly 1,700 employees.
With operations extending across more than 60 countries, we have established a strong foothold in major markets such as North America, Europe, Japan, South Korea, and the Middle East & North Africa. During the year, the Company prioritized initiatives focused on cost efficiency, capacity enhancement, operational excellence, inventory optimization, and employee development.
Driven by a clear strategic vision, the Company remains optimistic about future growth opportunities and committed to delivering sustainable long-term value to all stakeholders.
3. DIVIDEND
The Board of Directors of the Company did not recommend final dividend for the financial year March 31, 2026.
In terms of Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), the Company has adopted a Dividend Distribution Policy.
The said Policy is available on the Company's website and can be accessed at investors page of our Company's websitehttps://solara.co.in/ uploads/2023/07/Dividend_Distribution_Policv.pdf.
4. TRANSFER TO RESERVES
Your Company does not propose to transfer any amount to the reserves for the year ending March 31, 2026.
5. SHARE CAPITAL
i) Authorized Capital
The Authorized Share Capital of the Company as on March 31, 2026, stood at '120,00,00,000/- divided into 12,00,00,000 equity shares of '10/- each. There was no change regarding the Authorized Capital of the Company during the year.
ii) Issued and Subscribed Capital
The Issued and Subscribed capital as of March 31, 2026, stood at ' 48,17,15,620/- divided into 4,81,71,562 equity shares of '10/- each. Changes in the Issued and Subscribed Capital of the Company are as under:
|
Particulars
|
No of Shares
|
Amount (')
|
|
April 01, 2025
|
4,80,53,022 equity shares of '10/- each.
|
48,05,30,220
|
|
Additions during the year
|
1,00,000 Equity shares of ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on May 15, 2025.
|
10,00,000
|
| |
9,000 Equity shares of face value ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on October 13, 2025.
|
90,000
|
| |
8,040 Equity shares of ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on November 05, 2025.
|
80,400
|
| |
1,500 Equity shares of ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on December 17, 2025
|
15,000
|
|
March 31, 2026
|
4,81,71,562 equity shares of '10/- each.
|
48,17,15,620
|
iii) Paid up capital
The Paid-up capital as at March 31, 2026, stood at ' 44,51,39,030.50/- divided into 3,61,72,807 equity shares of '10/- each, 1,18,32,948 equity shares of ' 7/- each and 1,65,807 Equity shares of face value ' 3.5/- each per share paid up. Changes in the paid-up capital of the Company are as under:
|
Particulars
|
No of Shares
|
Amount (')
|
|
April 01, 2025
|
3,60,54,267 equity shares of '10/- each; 11,19,98,755 Equity shares of ' 10/- each ' 3.5 per share paid up
|
40,25,38,312.50
|
|
Additions during the year
|
1,00,000 Equity shares of ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on May 15, 2025, and ' 10/- paid up per share
|
10,00,000.00
|
| |
Receipt of Rights issue First call money of face value of '3.5 per share on 1,13,89,767 equity shares.
|
3,98,64,184.50
|
| |
9,000 Equity shares of face value ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on October 13, 2025, and ' 10/- paid up per share
|
90,000.00
|
| |
Receipt of Rights issue First call money of face value of '3.5 per share on 3,71,779 equity shares
|
13,01,226.50
|
| |
8,040 Equity shares of ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on November 05, 2025.
|
80,400.00
|
| |
1,500 Equity shares of ' 10/- each allotted pursuant to exercise of Options under ESOP Scheme 2018 on December 17, 2025
|
15,000.00
|
| |
Receipt of Rights issue First call money of face value of '3.5 per share on 71,402 equity shares
|
2,49,907.00
|
|
March 31, 2026
|
3,61,72,807 equity shares of '10/- each; 1,18,32,948 equity shares of ' 7/- each paid up and 1,65,807 equity shares of '3.5/- each paid up
|
44,51,39,030.50
|
6. RIGHTS ISSUE
On May 9, 2024, the Rights Issue Committee at its meeting approved the issuance of 1,19,98,755 Equity Shares of face value of ' 10 each at a price of ' 375 per Equity Share (including a premium of ' 365 per Equity Share), to existing equity shareholders on the record date (May 15, 2024) on 'rights' basis for an amount aggregating to ' 449.95 Crores. The issue was on a partly paid-up basis with 3 calls, i.e., application money, first call and second call. On June 19, 2024, Company allotted 1,19,98,755 partly paid - up Equity Shares on receipt of Application money of ' 131.25/- per equity share, which was aggregating to ' 157.48 Crores.
The Rights Issue Committee at its meeting held on March 26, 2025 approved the First Call Money Notice to the holders of Partly Paid-Up Equity Shares for ' 131.25/- (i. e ' 3.50/- towards face value and ' 127.75/- towards securities premium). The
Company sent two reminder notices dated July 01, 2025 and February 04, 2026 for payment of First Call Money.
Further, the Company also issued Second and Final Call Notice dated April 06, 2026 pursuant to the approval of Rights Issue Committee at its meeting held on Tuesday, March 24, 2026, for payment of '112.50/- (comprising of ' 3/- towards face value and ' 109.50/- towards securities premium) per partly paid-up Rights equity share towards Second and Final Call. Subsequent to the close of the financial year, the Company received an amount of ' 1,29,94,28,775 (Rupees One Hundred Twenty-Nine Crore Ninety-Four Lakh Twenty-Eight Thousand Seven Hundred Seventy-Five only) towards the Second and Final Call in respect of 1,15,50,478 partly paid-up Rights Equity Shares. Consequently, these shares were converted into fully paid-up Equity Shares of face value of ' 10 each on May 15, 2026.
As on March 31, 2026, total funds received from the Rights Issue was ' 309.79 crores including collection towards First Call of ' 155.31 Crore.
7. EMPLOYEES STOCK OPTION PLAN (ESOP)
The Company has two ESOP Schemes:
• Solara Employees Stock Option Plan 2018
• Solara Employee Stock Option Plan - 2024
A statement giving detailed information on stock options granted to Employees under the ESOP Plan as required under Section 62 of the Act, read with Rule 12 of Companies (Share Capital and Debentures) Rules, 2014 and Regulation 14 of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 is enclosed as Annexure-A to this Report and is also available athttps://www.solara. co.in/investor-relations/9th-agm-2026/.
The Company has also obtained a certificate from the Secretarial Auditor of the Company, as required under Regulation 13 of the SEBI (SBEB & SE) Regulations, that the Scheme has been implemented in aforesaid Regulations and in accordance with the resolution of the Company in the general meeting.
8. MATERIAL CHANGES AFFECTING THE FINANCIAL POSITION OF THE COMPANY
Subsequent to the close of the financial year, the Company received an amount of ' 1,29,94,28,775 (Rupees One Hundred Twenty-Nine Crore Ninety- Four Lakh Twenty-Eight Thousand Seven Hundred Seventy-Five only) towards the Second and Final Call on 1,15,50,478 partly paid-up Rights Equity Shares. Consequent upon receipt of the Second and Final Call money, these Rights Equity Shares were converted from ' 7 per share paid-up equity shares to fully paid-up equity shares of face value ' 10 per share pursuant to approval from the Rights Issue committee on May 15, 2026.
Except as stated above, there were no material changes or commitments affecting the financial position of the Company between the end of the financial year and the date of this Report.
9. SUBSIDIARIES, ASSOCIATES AND JOINT VENTURE COMPANIES
i) Changes during the year:
- During the year, Synthix Global Pharma Solutions Limited (“Synthix") was incorporated as a wholly- owned subsidiary of the Company on April 29, 2025.
- Solara Active Pharma Sciences LTDA, Brazil, non-material wholly owned subsidiary of the Company has been voluntarily deregistered with Federal Revenue of Brazil with effect from July 30, 2025, as it was non-operational/had no business activities.
The Company has the following subsidiaries as on March 31, 2026:
|
Name of the Company
|
Nature of relationship
|
India / Overseas
|
|
Synthix Global
|
Wholly - owned
|
India
|
|
Pharma Solutions Limited
|
subsidiary
|
|
|
Chemsynth Laboratories Private
|
Subsidiary
|
India
|
|
Limited
|
|
|
|
Shasun USA Inc
|
Subsidiary
|
Overseas
|
ii) Material Subsidiaries
The Company has adopted a 'Policy for determining Material Subsidiaries' as stipulated in explanation to Regulation 16(1)(c) of the SEBI Listing Regulations. The said policy may be accessed on the website of the Company athttps://solara.co.in/uploads/2023/07/ Policy-for-determining-of-Material-Subsidiaries.pdf. The Company did not have any material subsidiary during the year under review.
iii) Information about the financial performance / financial position of the subsidiaries
In accordance with Section 129(3) of the Act, a statement highlighting the key features of the financial statements of the subsidiary companies is included in Form AOC-1 as Annexure B - as a part of this report.
Further, pursuant to the provisions of Section 136 of the Act, the Consolidated Financial Statements, along with the relevant documents and the separate audited financial statements of the subsidiaries, are available on the Company's website at:https://solara. co.in/investor-relations/subsidiary-financials/#subs
10. CORPORATE GOVERNANCE
Your Company remains committed to upholding the highest standards of Corporate Governance and consistently complies with the Corporate Governance requirements prescribed under the Listing Regulations.
The detailed report on Corporate Governance as per the format prescribed by Securities and Exchange Board of India under Schedule V of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations") along with a certificate from Ms. Parimala Natarajan, Practicing Company Secretaries, confirming compliance with the requirements of Corporate Governance is attached with this report. There are no observations or adverse remarks in the said certificate.
Pursuant to the requirements of the Listing Regulations, a certificate from Ms. Parimala Natarajan, Practicing Company Secretary, confirming
that none of the directors of the Company are debarred or disqualified from being appointed or continuing as directors of any company, forms part of this Report.
11. MANAGEMENT DISCUSSION AND ANALYSIS
Pursuant to Regulation 34(2) (e) read with Schedule V of Listing Regulations “Management Discussion and Analysis Report" (“MD&A") for the financial year 2025-2026 forms part of this Report.
12. NUMBER OF MEETINGS OF THE BOARD OF DIRECTORS
Five meetings of the Board of Directors were held during the year. The gap between any two consecutive meetings did not exceed one hundred and twenty days. The details of the meetings held, and the attendance of each Director are provided in the Corporate Governance Report.
13. DIRECTORS & KEY MANAGERIAL PERSONNEL
i) Board of Directors:
As on date of this report, the Board has eight directors comprising of two (2) Executive Directors, two (2) Non-Executive Directors and four (4) Independent Directors. The Chairman of the Board is an Independent Director. The details of each member of the Board as on the date of this report forms part of the Corporate Governance Report.
|
Sl.
No
|
Name of the Directors
|
Designation
|
|
1
|
Mr. R Ramakrishnan (DIN: 00161542)
|
Independent Director and Chairperson
|
|
2
|
Dr. Kausalya Santhanam (DIN: 06999168)
|
Independent
Director
|
|
3
|
Prof. Rajendra Kumar Srivastava (DIN: 07500741)
|
Independent
Director
|
|
4
|
Mr. Rajiv Vijay Nabar (DIN: 10383397)
|
Independent
Director
|
|
5
|
Mr. Arun Kumar Pillai (DIN: 00084845)
|
Non-Executive
Director
|
|
6
|
Mr. Sandeep Shashikantha Rao (DIN: 10838251)
|
Managing Director & CEO
|
|
7
|
Mr. Manish Gupta (DIN: 06805265)
|
Non-Executive
Director
|
|
8
|
Mr. Mohanraj Sanjeevi (DIN: 08420411)
|
Whole Time Director
|
ii) Retiring by Rotation:
In accordance with the provisions of Section 152 of the Act, Mr. Arun Kumar Pillai (DIN: 00084845), Non - Executive Director, retires by rotation at the ensuing Annual General Meeting and being eligible, offers himself for reappointment. Your directors recommend his reappointment and accordingly, suitable resolution proposing his re- appointment forms part of the Notice of the AGM.
Detailed profile of the Director retiring by rotation is provided in the explanatory statement of the 9th AGM notice.
iii) Changes in the Board of Directors and Key Managerial Personnel during the year and till the date of this Report is as under:
The following changes in the composition of the Board of Directors and Key Managerial Personnel occurred during the period under review.
• Mr. S. Murali Krishna retired from the position of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company with effect from the closing of the business hours of May 15, 2025.
• Ms. Pooja Jaya Kumar joined as the Company Secretary & Compliance Officer and Key Managerial Personnel of the Company with effect from the closing of the business hours of May 15, 2025.
• Mr. Mohan Muthunarayanan, Whole-time Director, who was liable to retire by rotation, was reappointed at the Eighth AGM held on September 25, 2025.
• Mr. Manish Gupta, Non-Executive Director, who was liable to retire by rotation, was reappointed at the Eighth AGM held on September 25, 2025.
• Mr. Kartheek Chintalapati Raju (DIN: 02921819), resigned from the position of Non-Executive Director of the Company, with effect from end of the business hours of November 05, 2025.
• Mr. Mohan Muthunarayanan (DIN: 03610282), resigned from the position of Whole Time Director (Executive Director) & Chief Operating Officer (Key Managerial Personnel) of the Company with effect from end of the business hours of December 31, 2025.
• Mr. Mohanraj Sanjeevi (DIN: 08420411) was appointed as an Additional Director, designated as Executive and Whole-time Director, for a term of three (3) years with effect from January 1, 2026, to December 31, 2028. Pursuant to the approval of the shareholders received on March 06, 2026, he has been appointed as Whole¬ Time Director of the Company.
In terms of provisions of Section 203 of the Act read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Key Managerial Personnel of the Company as on the date of this report are:
• Mr. Sandeep Shashikantha Rao, Managing Director & Chief Executive Officer
• Mr. Mohanraj Sanjeevi, Whole Time Director & Chief Human Resources Officer
• Mr. Sarat Kumar, Chief Financial Officer
• Ms. Pooja Jaya Kumar, Company Secretary
14. DECLARATION BY INDEPENDENT DIRECTORS
In accordance with Section 149(7) of the Companies Act, 2013 each Independent Director has confirmed to the Company that he / she meets the criteria of independence as laid down in Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of the Listing Regulations and that they are not aware of any circumstances or situations, which exists or may be reasonably anticipated that could impair or impact their ability to discharge duties with an objective independent judgement and without any external influence. Independent Directors of the Company have also confirmed that they have complied with the Code for Independent Directors as prescribed in Schedule IV of the Act.
The Independent Directors of the Company have also registered their names in the data bank for Independent Directors maintained by the Indian Institute of Corporate Affairs (IICA), Manesar. In the opinion of the Board, all Independent Directors are independent of the management and possess requisite qualifications, experience and expertise.
During the year under review, one meeting of Independent Directors was held on February 6, 2026. This meeting was conducted without the presence of other Non-Independent Directors and members of management. During the meeting, the Independent Directors evaluated the performance of the Non-Independent Directors, the Chairman, and the Board as a whole. They also assessed the quality, quantity, and timeliness of the information flow between the Company's management and the Board of Directors.
15. BOARD EVALUATION
Pursuant to the provisions of Regulation 17(10) of the Listing Regulations read with Regulation 25 (4) and Section 178 (2) of the Companies Act, 2013, and in accordance with the Company's Board Evaluation Policy, a formal evaluation of the performance of the Board and its Committees as a whole and individual Directors including Independent Directors, Non-Independent Directors and Chairperson individually has been carried out. In pursuant thereof, annual evaluation of performance of the Board, working of its committees, contribution and impact of individual directors has been carried out through a questionnaire for peer evaluation on various parameters.
Performance Evaluation Criteria for Independent Directors:
The performance evaluation criteria for Independent Directors are determined by the NRC Committee. An indicative list of factors on which evaluation was carried out includes participation and contribution by a director in meetings, commitment, effective deployment of knowledge and expertise, integrity and maintenance of confidentiality and independence of behaviour and judgment. Performance evaluation of the Independent Directors was done by the entire Board, excluding the Independent Director being evaluated. Outcome of the evaluation process was positive, and the Directors expressed satisfaction with the performance of the Board, its Committees, and individual Directors. The details of the evaluation process are set out in the Corporate Governance Report which forms part of this Annual Report.
16. PARTICULARS OF EMPLOYEES
The statement containing particulars in terms of Section 197(12) of the Companies Act, 2013 read with rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 forms part of this report and is appended herewith as Annexure C - to the Boards' report
The statement containing particulars in terms of Section 197(12) ofthe Companies Act, 2013 read with rule 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is to be provided. Considering the first proviso to Section 136(1) of the Companies Act, 2013, the Annual Report, excluding the aforesaid information, is being sent to the members of the Company and others entitled thereto. The said information is available for electronic inspection during working hours and any member interested in obtaining such information may write to the Company Secretary and the same will be furnished on request.
17. CORPORATE SOCIAL RESPONSIBILITY (CSR)
The Company has undertaken “Corporate Social Responsibility (CSR)", initiatives in areas of Health & Safe Drinking water and Education. A detailed report on CSR activities undertaken during the financial year 2025-26 is enclosed as Annexure D - in this Report.
18. RISK MANAGEMENT
The Company has a risk management framework for the identification and management of risks. In line with the requirement under the SEBI Listing Regulations, the Company has constituted a Risk Management Committee (“RMC"), comprising of members of the Board and KMP. Composition of RMC is provided in the Corporate Governance Report, which forms part of this Report.
The RMC is entrusted with the responsibility of overseeing strategic, operational, financial and Compliance risks that the organization faces, along with the adequacy of mitigation plans to address such risks.
Additional details relating to Risk Management are provided in the Management Discussion and Analysis report forming part of this Report.
19. LOANS, GUARANTEES OR INVESTMENTS
Pursuant to Section 134(3)(g) of the Companies Act, 2013, the particulars of investments made, loans given and guarantees provided under the provisions of Section 186 of the Companies Act, 2013 are provided in the Standalone Financial Statements in the Annual Report (Please refer to Note No. 9, 10 and 39C to the Financial Statements).
20. CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES
All related party transactions or arrangements entered into by the company during the financial year were on an arm's length basis and in the ordinary course of business. In Compliance with the provisions of the Act and Regulation 23(2) of the Listing Regulations, all related party transactions including that transaction which required omnibus approval had been placed before the Audit Committee for prior approval.
The transactions with related parties are disclosed in Note No. 39 to the Standalone Financial Statements in the Annual Report. Information on transactions with related parties pursuant to Section 134(3)(h) of the Companies Act 2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014 in Form AOC-2 is enclosed as Annexure- E to this Report. Further, there are no materially significant related party transactions with its promoters, the directors or the management, their subsidiaries, or relatives, etc. that may have potential conflict with the interests of the Company at large.
The Company has formulated a policy for transacting with Related Parties, which is uploaded on the website of the Company and can be viewed athttps://solara.co.in/uploads/2026/6/RPT_ policy_2026_V4.pdf?V =178097 9142. During the year under review, the said Policy was reviewed and amended by the Audit Committee and Board to align with the regulatory amendments.
21. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS
There are no significant and material orders passed by the Regulators / Courts that would impact the going concern status of the Company and its future operations.
22. AUDITORS AND AUDIT REPORTS
i) Statutory Auditors
M/s. DeloitteHaskins&Sel ls LLP,CharteredAccounta nts (Firm Registration No.117366W/W-100018) were reappointed as Statutory Auditors of the Company at the Sixth Annual General Meeting of the Company held on September 15, 2023, for a period of 4 years and will hold the office till the conclusion of the 10th AGM of the Company.
The Auditor's report to the shareholders on the standalone and consolidated financial statement for the year ended March 31, 2026, does not contain any qualification, observation or adverse comment. Further, there were no fraud reported by the Statutory Auditor to the Audit Committee or the Board under Section 143(12) of the Act.
ii) Secretarial Auditors
Ms. Parimala Natarajan, Practicing Company Secretaries, Chennai, a peer reviewed Practicing Company Secretary (CoP No. 5239), was appointed as the Secretarial Auditor of the Company for a period of 5 consecutive years, from April 1, 2025, to March 31, 2030.
The Secretarial Audit for the financial year 2025-26, inter-alia, included audit of compliance with the Companies Act, 2013, and the Rules made under the Act, Listing Regulations and applicable Regulations prescribed by SEBI amongst others.
The Secretarial Audit Report for the financial year 2025-26 issued by the Secretarial Auditor is enclosed as Annexure F to the Board's Report.
There are no observations or Remarks in the Secretarial Audit Report.
iii) Internal Auditors
M/s. Grant Thornton Bharat LLP (formerly known as Grant Thornton India LLP) (LLPIN: AAA-7677), Chartered Accounting Firm, are the Internal Auditors of the Company for the Financial year 2025-2026. The Internal Auditors carried out the audit as per the audit plan defined by the Audit Committee and regularly updated the committee on their internal audit findings at the Committee's meetings.
The Internal Auditors were satisfied with the management's response on the observation and recommendations made by them during the course of their audit and have expressed satisfaction with the internal systems, controls and process followed by the Company.
iv) Cost Auditors and Cost Records
Your Company has duly maintained cost accounts and records as specified by the Central Government under sub section (1) of Section 148 of the Act and the relevant rules made thereunder.
Mr. K. Suryanarayanan, Cost Accountant (Membership No.24946) has carried out the Cost Audit for the applicable business for the year under review.
Pursuant to the provisions of Section 148(3) of the Companies Act, 2013, the Board of Directors of the Company at their meeting held on May 15, 2026, based on the recommendation of Audit Committee, approved appointment of Mr. K. Suryanarayanan, Cost Accountant (Membership No.24946), as the Cost Auditor of the Company for financial year ended 2027 (FY27) at a remuneration of ' 4.75 lakhs/- (Rupees Four Lakhs and Seventy-Five Thousand) plus applicable taxes and reimbursement of out- of-pocket expenses. A proposal for ratification of remuneration of the Cost Auditors for FY27 is placed before the Shareholders for approval in the ensuing AGM.
The Company has received consent from Mr. K. Suryanarayanan, Practicing Cost Accountants, to serve as Cost auditors of the Company for the financial year 2027. The Company has also received necessary certificate under Section 141 of the Act, 2013 from them conveying their eligibility to act as Cost Auditor.
Further, the Company has duly maintained Cost accounts and records as specified under sub¬ section (1) of section 148 read with the provision of Companies (Cost Records and Audit) Rules, 2014 of the Companies Act, 2013.
23. INTERNAL FINANCIAL CONTROLS
The Company has in place well defined and adequate framework for Internal Financial Controls (“IFC”) as required under Section 134 (5) (e) of the Companies Act, 2013, commensurate with the size, scale, and complexity of its operations.
During the year under review, such controls were tested and no material weaknesses in their design or operations were observed as the Company has, in all material respects, maintained adequate internal financial controls over financial reporting as of March 31, 2026, and are operating effectively.
24. OTHER DISCLOSURES
i) Nature of Business of the Company
There has been no change in the nature of business of the Company during the year under review.
ii) Public Deposits
The Company has neither invited nor accepted any deposits from the public falling within the purview of provisions of Section 73 read with Chapter V - Acceptance of Deposits by Companies of the Companies Act, 2013 and Companies (Acceptance of Deposits) Rules, 2014.
iii) Credit Rating
During the year under view, CRISIL has reaffirmed credit rating of CRISIL BBB / stable (outlook revised from Negative; Rating- reaffirmed) for long term debt and CRISIL A3 (Reaffirmed) for short term debt.
iv) Vigil Mechanism / Whistle Blower Policy
The Company, in compliance with Section 177 of the Companies Act, 2013 and Regulation 22 of Listing Regulations has established a Whistle Blower Policy in place as part of its vigil mechanism. The policy provides appropriate avenues to the directors, employees and stakeholders of the Company to make protected disclosures in relation to matters concerning the Company. Protected disclosures are appropriately reviewed and addressed by the Whistle Officer, while disclosures involving Senior Management Personnel and Directors are reviewed and handled by the Chairman of the Audit Committee. The policy is also available on the Company's website athttps://solara.co.in/ uploads/2026/5/Whistle-Blower-Policy_2026. pdf?v=1778852330
v) Policy on Directors Appointment and Remuneration
The policy of the Company on Directors' appointment and remuneration, including the criteria for determining qualifications, positive attributes, independence of a director and other matters, as required under Section 178 of the Companies Act, 2013 is available on the Company's website at the below given link:
https://solara.co.in/uploads/2025/1/Solara_
Nomination_Remuneration_Policy.pdf
vi) Insurance
The assets/ properties of the Company are adequately insured against loss due to fire, riots, earthquake, terrorism, etc., and against other perils that are considered necessary by the management.
vii) Annual Return
Pursuant to Section 92 of the Act and Rules made thereunder, Annual Return of the Company as on March 31, 2026, is available on the website of the Company and can be accessed athttps://solara. co.in/investor-relations/annual-return/
25. OTHER CONFIRMATIONSi) General:
During the year under review, the Company has not made any application under the Insolvency and Bankruptcy Code, 2016 and no proceedings are pending under the Insolvency and Bankruptcy Code, 2016 during the year. During the year, there was no one-time settlement done with the Banks or Financial Institutions.
ii) Statement on Maternity Benefit Compliance:
The Company further affirms full compliance with the provisions of the Maternity Benefit Act, 1961. The Company remains committed to upholding the rights and welfare of its female employees by providing all statutory maternity benefits as mandated under the Act.
iii) Secretarial standards issued by the Institute of Company Secretaries of India (ICSI)
The Directors state confirms that pursuant to the provisions of Section 118(10) of the Act, the Company has complied with the applicable provisions of the applicable Secretarial Standards issued by the Institute of Company Secretaries of India (ICSI) during the Financial Year 2025-26.
iv) Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo:
Particulars in respect of conservation of energy, technology absorption and foreign exchange earnings and outgo as required under section 134 of the Companies Act, 2013, read with Rule 8(3) of the Companies (Accounts) Rules, 2014 is attached as Annexure G to this Report.
v) Disclosure under the Sexual harassment of woman at workplace (Prevention, Prohibition and Redressal) Act, 2013:
The Company has put in place an anti-sexual harassment mechanism in line with the requirements of the Sexual Harassment of Women at the Workplace (Prevention, Prohibition & Redressal) Act, 2013. The Company has complied with the constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, to redress the complaints received regarding sexual harassment. All employees (permanent, contractual, temporary, trainees) are covered under this policy. The Company has not received any complaint of sexual harassment during the year 2025-26.
The Internal Committee of the Company has filed annual return for the calendar year 2026 at its jurisdictional office, as required under Section 21(1) of the Sexual Harassment of Women at Workplace
(Prevention, Prohibition and Redressal) Act, 2013 read with Rule 14 of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Rules, 2013. The following is the summary of the complaints received and disposed off during the financial year 2025-26:
I. Number of complaints of sexual harassment received in the year: Nil
II. Number of complaints disposed off during the year: Nil
III. Number of cases pending for more than ninety days: Nil
Further, the Company organizes and conducts various training programmes on a periodic basis to enhance awareness and understanding of the provisions of the POSH Act.
vi) Investor Education and Protection Fund:
Details pertaining to unpaid and unclaimed dividend transferred to IEPF are provided under Corporate Governance Report, which forms part of this Annual Report.
26. DIRECTORS' RESPONSIBILITY STATEMENT
Pursuant to the provisions of Section 134(5) of the Companies Act, 2013 the Directors of your Company confirm that:
a) in the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.
b) they have selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year and of the profit or loss of the company for that period;
c) they have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities.
d) they have prepared the annual accounts on a going concern basis.
e) they have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and operating effectively; and
f) they have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
27. BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT
As stipulated under the Listing Regulations, the Business Responsibility and Sustainability Report (BRSR) describing the initiatives taken by the Company from environmental, social and governance perspective is provided separately and forms integral part of this Annual Report. BRSR as a part of Annual Report is available on the company's website.
28. ACKNOWLEDGEMENT
Your directors place on record their sincere appreciation for the dedicated services and continued commitment of all employees of the Company. Directors also extend their gratitude for the consistent support and cooperation received from banks, government and regulatory authorities, stock exchanges, customers, vendors.
For and on behalf of the Board of Directors
Sandeep Shashikantha Rao Mohanraj Sanjeevi
Place: Ooty Managing Director & CEO Whole Time Director
Date: May 15, 2026 DIN: 10838251 DIN: 08420411
|